V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160016234 | 160008047 | 1.71 | 58.1 | Neo-adjuvant (N) | 2018-08-20 | 2018-09-05 | DOXORUBICIN | N | null | LIPOSOMAL DOXORUBICIN | 101787831 |
| 160016235 | 160008048 | 0 | 45 | Palliative (P) | 2019-03-03 | 2019-03-04 | Carboplatin AUC 2 - 5 | N | N | CARBOPLATIN | 101737079 |
| 160016237 | 160008049 | 1.89 | 156 | Curative (C) | 2019-05-18 | 2019-05-31 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100297731 |
| 160016240 | 160008050 | 1.59 | 59 | Palliative (P) | 2018-06-23 | 2018-07-01 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100737869 |
| 160016241 | 160008051 | 1.59 | 104 | 03 | 2019-01-20 | 2019-02-04 | Carboplatin AUC 6 - 10 | null | N | CARBOPLATIN | 101610471 |
| 160016242 | 160008052 | 1.78 | 84.8 | Palliative (P) | 2020-01-14 | 2020-01-16 | NB HRNBL-1 COJEC Ind COURSE B | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100184758 |
| 160016245 | 160008053 | 1.76 | 108 | Neo-adjuvant (N) | 2019-02-20 | 2019-03-19 | EC | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100379331 |
| 160016247 | 160008054 | 1.77 | 92.3 | Palliative (P) | 2016-05-20 | 2016-06-14 | Liposomal Doxorubicin (20mg/m2) | N | N | EW EUROEWING 2012 ARM A VIDE | 100757978 |
| 160016250 | 160008055 | 1.57 | 72.2 | null | 2019-01-07 | 2019-01-23 | Pemetrexed | 2 | null | CAV | 101735056 |
| 160016251 | 160008056 | 1.89 | 72.2 | null | 2020-01-01 | 2020-01-01 | Doxorubicin + Olaratumab | null | Y | IVA | 100455664 |
| 160016255 | 160008057 | null | 71.3 | Neo-adjuvant (N) | 2018-08-27 | 2018-08-28 | NIVOLUMAB | 2 | null | DOXORUBICIN + IFOSFAMIDE | 101481100 |
| 160016256 | 160008058 | 1.6 | 71.1 | Palliative (P) | 2016-10-21 | 2016-12-01 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101575658 |
| 160016259 | 160008059 | 1.67 | 80.6 | Neo-adjuvant (N) | null | 2016-11-30 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100709497 |
| 160016261 | 160008060 | 1.63 | 78.3 | null | 2016-10-28 | 2016-11-04 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101031973 |
| 160016262 | 160008061 | 1.68 | 90.3 | Palliative (P) | 2019-06-30 | 2019-06-30 | DOXORUBICIN | null | N | DOXORUBICIN + IFOSFAMIDE | 100613752 |
| 160016264 | 160008062 | 1.73 | 93.1 | Curative (C) | 2016-08-21 | 2016-09-27 | ETOP 13-18 BEAT-meso Trial | 02 | N | DOXORUBICIN + OLARATUMAB | 100463884 |
| 160016266 | 160008063 | 1.58 | 76 | Curative (C) | 2016-06-04 | 2016-07-09 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101145444 |
| 160016267 | 160008064 | 1.78 | 72.7 | Adjuvant (A) | 2017-12-23 | 2017-12-23 | Cisplatin + Pemetrexed | Y | N | CISPLATIN + PEMETREXED | 101666125 |
| 160016268 | 160008065 | 1.62 | 58.4 | Palliative (P) | 2017-11-25 | 2017-12-01 | Doxorubicin + Ifosfamide | N | N | LIPOSOMAL DOXORUBICIN | 101200519 |
| 160016271 | 160008066 | 0 | 90 | Palliative (P) | 2020-04-29 | 2020-04-30 | BENDAMUSTINE + RITUXIMAB | 02 | null | ENZALUTAMIDE | 100297163 |
| 160016272 | 160008067 | 1.56 | 68.8 | null | 2017-06-22 | 2017-06-28 | Carboplatin + Paclitaxel (weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 101456842 |
| 160016276 | 160008068 | 1.78 | 61 | Palliative (P) | 2019-01-14 | 2019-01-23 | null | 02 | Y | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 101766527 |
| 160016279 | 160008070 | 1.67 | 57.7 | Palliative (P) | null | 2019-03-23 | CYCLOPHOSPHAMIDE + EPIRUBICIN | 02 | N | CTD | 100874490 |
| 160016280 | 160008071 | 1.73 | 82.9 | Palliative (P) | null | null | ETOPOSIDE + IFOSFAMIDE | 02 | N | TRIAL UNSPECIFIED | 101433050 |
| 160016281 | 160008072 | 1.85 | 92.4 | Disease modification (D) | 2018-06-28 | 2018-06-29 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101818173 |
| 160016282 | 160008073 | 1.85 | 84 | Palliative (P) | 2020-11-06 | 2020-11-22 | Doxorubicin 75mg/m2 | null | N | DOXORUBICIN | 100190812 |
| 160016283 | 160008074 | 1.5 | 104.6 | Palliative (P) | 2018-03-29 | 2018-04-25 | DOXORUBICIN | 02 | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 101060221 |
| 160016284 | 160008075 | 1.63 | 88.6 | Palliative (P) | 2016-08-14 | 2016-08-21 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100535535 |
| 160016285 | 160008076 | 1.65 | 81.8 | Palliative (P) | 2019-04-16 | 2019-04-19 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100436203 |
| 160016286 | 160008077 | 1.74 | 79 | Curative (C) | 2016-10-01 | 2016-10-01 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 100092096 |
| 160016287 | 160008078 | 1.55 | 100.3 | Neo-adjuvant (N) | 2018-06-13 | 2018-06-14 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101210219 |
| 160016288 | 160008079 | 1.56 | 66 | Curative (C) | 2013-05-08 | 2018-11-27 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101767558 |
| 160016291 | 160008080 | 1.61 | 84 | Palliative (P) | 2018-01-27 | 2018-01-27 | Carboplatin AUC 6 - 10 | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100344862 |
| 160016293 | 160008081 | 1.78 | 68.6 | null | null | 2018-01-22 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100813274 |
| 160016294 | 160008082 | null | null | null | 2018-08-27 | 2018-09-09 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | null | LIPOSOMAL DOXORUBICIN | 100012257 |
| 160016296 | 160008083 | 1.72 | 110 | Palliative (P) | 2017-05-20 | 2017-06-07 | CARBOPLATIN + ETOPOSIDE | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100134994 |
| 160016298 | 160008084 | 1.68 | 83.6 | Neo-adjuvant (N) | 2016-04-23 | 2016-05-18 | Doxorubicin 75mg/m2 | 02 | Y | DOXORUBICIN | 100029791 |
| 160016299 | 160008085 | 1.74 | 81.5 | Neo-adjuvant (N) | 2018-10-06 | 2018-10-10 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 101510050 |
| 160016301 | 160008086 | 1.77 | 52.5 | Palliative (P) | 2016-09-07 | 2016-09-21 | null | 02 | null | DOXORUBICIN + IFOSFAMIDE | 100811274 |
| 160016302 | 160008087 | 0 | 58 | Curative (C) | 2018-04-11 | 2018-04-12 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100401926 |
| 160016304 | 160008088 | 1.68 | 83.6 | Palliative (P) | 2018-04-08 | 2018-04-08 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100017071 |
| 160016305 | 160008089 | 1.72 | 67.7 | Palliative (P) | 2021-06-24 | 2021-07-07 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101769881 |
| 160016307 | 160008090 | 1.7 | 74.6 | Palliative (P) | 2017-09-01 | 2017-09-06 | Enzalutamide | 02 | N | EPSSG | 100095618 |
| 160016308 | 160008091 | 1.68 | 113 | Palliative (P) | 2019-02-01 | 2019-02-22 | Doxorubicin + Ifosfamide | 02 | null | IXAZOMIB + LENALIDOMIDE | 101681747 |
| 160016309 | 160008092 | 1.6 | 53 | Palliative (P) | 2016-10-19 | 2016-11-02 | null | 02 | null | STS RHABDO RMS 2005 VIN CYCLO | 100318550 |
| 160016311 | 160008093 | 1.88 | 82 | Palliative (P) | null | 2018-07-01 | Bendamustine+Rituximab (1st Course) | 02 | N | DOCETAXEL + GEMCITABINE | 101522429 |
| 160016314 | 160008094 | 1.68 | 61 | null | 2016-06-18 | 2016-06-18 | CARBOPLATIN + PACLITAXEL | Y | N | CARBOPLATIN + PACLITAXEL | 100726127 |
| 160016316 | 160008095 | 1.78 | 82.2 | Curative (C) | 2017-04-09 | 2017-04-25 | VIDE | 02 | N | LIPOSOMAL DOXORUBICIN | 100605956 |
| 160016320 | 160008096 | 1.7 | 78.5 | Palliative (P) | 2016-05-18 | 2016-06-02 | Ifosfamide | 02 | N | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 101769475 |
| 160016321 | 160008097 | 1.8 | 80 | Palliative (P) | null | 2019-08-22 | Bevacizumab | null | N | CISPLATIN + DOXORUBICIN | 100286336 |